Journal of Gastrointestinal Surgery

, Volume 16, Issue 9, pp 1648–1650

Proteomics, Genomics, and Molecular Biology in the Personalized Treatment of Colorectal Cancer

SSAT State-of-the-Art Conference

DOI: 10.1007/s11605-012-1942-2

Cite this article as:
Carethers, J.M. J Gastrointest Surg (2012) 16: 1648. doi:10.1007/s11605-012-1942-2


Colorectal cancer develops and progresses from genetic and genomic changes that occur within and transforms the growth behavior of a normal colonic cell. Molecular tools have advanced enough to allow the scientific community to probe deeper into risk alleles within a population as well as into individual patient genetic data that can ascribe such a risk. Detected genetic and genomic changes from colorectal cancer can help determine a patient’s prognosis, predict response to chemotherapy, and determine the approach to care with biological therapies. Utilizing stool, blood/plasma, and tumor tissue to obtain genetic, genomic, and pharmacokinetic information contribute to a person’s profile to direct specific cancer care.


Colorectal cancer Personalized medicine Genetics Genomics DNA mismatch repair KRAS EGFR Cancer staging 

Copyright information

© The Society for Surgery of the Alimentary Tract 2012

Authors and Affiliations

  1. 1.Division of Gastroenterology, Department of Internal MedicineUniversity of MichiganAnn ArborUSA

Personalised recommendations